Status: Not yet recruiting
Updates and Insights on HER2 in Breast Cancer in Sohag Governorate
* To evaluate HER2 expression in breast carcinoma with emphasizing HER2-ultralow, and HER2-low, HER2 equivocal tumors. * To correlate the results of HER2 with clinico-pathological prognostic parameters; examples tumor grade, Ki-67 proliferation index, nodal status, tumor size, lympho-vascular invasion, and perineural invasion, tumor infiltrating lymphocytes * To access interobserval agreement in HER2 score interpretation
Participants needed: 100
Trial details
Age: 26-85Biological sex: FemaleType: ObservationalSponsor: Sohag UniversityUpdated: Aug 12, 2026Locations: 1
Eligibility criteria
Breast cancer cases diagnosed during 2025 and 2026. [+4]
Cases with insufficient, destroyed, necrotic, or unavailable tissue blocks. [+3]